Biologics Market Global Report 2017
出 版 商：TBRC
出版日期：2017/07/17
頁 數：250頁
文件格式：PDF
價 格：
USD 6,000 (Single-User License)
USD 9,000 (Multi-User License)
USD 12,000 (Global-User License)
USD 6,000 (Hard copy)
USD 9,000 (Multi-User License)
USD 12,000 (Global-User License)
USD 6,000 (Hard copy)
Biologics provide effective treatment for many complex diseases such as Rheumatoid arthritis that have less treatment options. There has been significant advancement for the treatment of Rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs.
The Biologics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global satellite and telecommunications resellers sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The biologics market section of the report gives context. It compares the biologics market with other segments of the pharmaceutical market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The biologics Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines
Companies Mentioned: Johnson & Johnson, Pfizer Inc., Novartis AG, Abbvie, and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Biologics Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
The Biologics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global satellite and telecommunications resellers sector.
Reasons to Purchase
‧ Outperform competitors using accurate up to date demand-side dynamics information.
‧ Identify growth segments for investment.
‧ Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
‧ Create regional and country strategies on the basis of local data and analysis.
‧ Stay abreast of the latest customer and market research findings
‧ Benchmark performance against key competitors.
‧ Develop strategies based on likely future developments.
‧ Utilize the relationships between key data sets for superior strategizing.
‧ Suitable for supporting your internal and external presentations with reliable high quality data and analysis
‧ Gain a global perspective on the development of the market.
‧ Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical market, and compares it with other markets.
‧ The market characteristics section of the report defines and explains the market.
‧ The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
‧ Market segmentations break down market into sub markets.
‧ The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
‧ Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
‧ The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
‧ The biologics market section of the report gives context. It compares the biologics market with other segments of the pharmaceutical market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The biologics Indicators Comparison.
‧ The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines
Companies Mentioned: Johnson & Johnson, Pfizer Inc., Novartis AG, Abbvie, and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Biologics Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Biologics Market Characteristics;
2. Biologics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Biologics Market Customer Information;
5. Biologics Market Segmentation;
5.1. Global Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 5.2. Global Biologics Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Biologics Market Trends And Strategies; 5.4 Global Biologics Market Compared With Similar Markets, 2016; 5.5 Global Biologics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6 Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Therapeutic Proteins; 5.8.1. Market Characteristics; 5.8.2. Global Internet Broadcasting & Publishing Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9 Monoclonal Antibodies (MABS); 5.9.1. Market Characteristics; 5.9.2. Global Internet Broadcasting & Publishing Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10 Vaccines; 5.9.1. Market Characteristics; 5.10.2. Global Internet Broadcasting & Publishing Market, 2016, By Segment; 5.10.3. Market Trends And Strategies;
6. Biologics Market Regional And Country Analysis;
6.1. Global Biologics Market, 2016, By Region; 6.2. Global Biologics Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Biologics Market, 2016, By Country; 6.4. Biologics Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceuticals Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceuticals Market Segments, 2016, By Country;
7. Global Biologics Market Comparison With Macro Economic Factors;
7.1. Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Biologics Expenditure, Global;
8. Biologics Market Comparison With Macro Economic Factors Across Countries;
8.1. Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Biologics Expenditure, By Country;
9. Biologics Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.10. Global Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.11. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.12. Global Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.13. Global Number Of Pharmacies, 2016, By Country; 9.14. Global Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.15. Global New Drug Approvals, 2016, By Country; 9.16. Global Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.17. Prevalent Cases Of Thalassemia, 2014, By Country; 9.18. Global Number Of General Practitioners 2016, By Country; 9.19. Global Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Biologics Market;
10.1.1. Asia-Pacific Biologics Market Overview; 10.1.2. Asia-Pacific Biologics Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Biologics Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.2. Asia-Pacific Biologics Market: Country Analysis; 10.3. China Biologics Market; 10.3.1. China Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Biologics Historic Market, 2012 - 2016; 10.3.3. China Biologics Forecast Market, 2016 - 2020; 10.3.4. China Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.3.5. China Biologics Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Biologics Expenditure, 2012 - 2020; 10.4. India Biologics Market; 10.4.1. India Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Biologics Historic Market, 2012 - 2016; 10.4.3. India Biologics Forecast Market, 2016 - 2020; 10.4.4. India Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.4.5. India Biologics Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Biologics Expenditure, 2012 - 2020; 10.5. Japan Biologics Market; 10.5.1. Japan Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Biologics Historic Market, 2012 - 2016; 10.5.3. Japan Biologics Forecast Market, 2016 - 2020; 10.5.4. Japan Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.5.5. Japan Biologics Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Biologics Expenditure, 2012 - 2020; 10.5.7. Japan Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.5.7.2. Japan Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.6. Australia Biologics Market; 10.6.1. Australia Biologics Historic Market, 2012 - 2016; 10.6.2. Australia Biologics Forecast Market, 2016 - 2020; 10.6.3. Australia Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.6.4. Australia Biologics Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Biologics Expenditure, 2012 - 2020;
11. Western Europe Biologics Market;
11.1.1. Western Europe Biologics Market Overview; 11.1.2. Western Europe Biologics Historic Market, 2012 - 2016; 11.1.3. Western Europe Biologics Forecast Market, 2016 - 2020; 11.1.4. Western Europe Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.2. Western Europe Biologics Market: Country Analysis; 11.3. UK Biologics Market; 11.3.1. UK Biologics Market Overview; Average Salaries Of Pharmacists; 11.3.2. UK Biologics Historic Market, 2012 - 2016; 11.3.3. UK Biologics Forecast Market, 2016 - 2020; 11.3.4. UK Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.3.5. UK Biologics Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Biologics Expenditure, 2012 - 2020; 11.3.7. UK Biologics Market Comparison With Industry Metrics; 11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.3.7.2 UK Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4. Germany Biologics Market; 11.4.1. Germany Biologics Historic Market, 2012 - 2016; 11.4.2. Germany Biologics Forecast Market, 2016 - 2020; 11.4.3. Germany Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.4.4 Germany Biologics Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Biologics Expenditure, 2012 - 2020; 11.4.6 Germany Biologics Market Comparison With Industry Metrics; 11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4.7.2 Germany Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5 France Biologics Market; 11.5.1 France Biologics Historic Market, 2012 - 2016; 11.5.2 France Biologics Forecast Market, 2016 - 2020; 11.5.3 France Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.5.4 France Biologics Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Biologics Expenditure, 2012 - 2020; 11.5.6 France Biologics Market Comparison With Industry Metrics; 11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5.6.2 France Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6. Italy Biologics Market; 11.6.1. Italy Biologics Historic Market, 2012 - 2016; 11.6.2. Italy Biologics Forecast Market, 2016 - 2020; 11.6.3. Italy Biologics Market, 2016, By Segment; Therapeutic Proteins; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.6.4. Italy Biologics Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Biologics Expenditure, 2012 - 2020; 11.6.6. Italy Biologics Market Comparison With Industry Metrics; 11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6.6.2 Italy Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7. Spain Biologics Market; 11.7.1. Spain Biologics Historic Market, 2012 - 2016; 11.7.2. Spain Biologics Forecast Market, 2016 - 2020; 11.7.3. Spain Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.7.4. Spain Biologics Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Biologics Expenditure, 2012 - 2020; 11.7.6. Spain Biologics Market Comparison With Industry Metrics; 11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7.6.2 Spain Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
12. Eastern Europe Biologics Market;
12.1.1. Eastern Europe Biologics Market Overview; 12.1.2. Eastern Europe Biologics Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Biologics Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 12.2. Eastern Europe Biologics Market: Country Analysis; 12.3. Russia Biologics Market; 12.3.1. Russia Biologics Historic Market, 2012 - 2016; 12.3.2. Russia Biologics Forecast Market, 2016 - 2020; 12.3.3. Russia Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 12.3.4. Russia Biologics Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Biologics Expenditure, 2012 - 2020;
13. North America Biologics Market;
13.1.1. North America Biologics Market Overview; 13.1.2. North America Biologics Historic Market, 2012 - 2016; 13.1.3. North America Biologics Forecast Market, 2016 - 2020; 13.1.4. North America Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 13.2. North America Biologics Market: Country Analysis; 13.3. USA Biologics Market; 13.3.1. USA Biologics Historic Market, 2012 - 2016; 13.3.2. USA Biologics Forecast Market, 2016 - 2020; 13.3.3 USA Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 13.3.4. USA Biologics Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Biologics Expenditure, 2012 - 2020; 13.3.6. USA Biologics Market Comparison With Industry Metrics; 13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 13.3.6.2 USA Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
14. South America Biologics Market;
14.1.1. South America Biologics Market Overview; 14.1.2. South America Biologics Historic Market, 2012 - 2016; 14.1.3. South America Biologics Forecast Market, 2016 - 2020; 14.1.4. South America Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 14.2. South America Biologics Market: Country Analysis; 14.3. Brazil Biologics Market; 14.3.1. Brazil Biologics Historic Market, 2012 - 2016; 14.3.2. Brazil Biologics Forecast Market, 2016 - 2020; 14.3.3. Brazil Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 14.3.4. Brazil Biologics Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Biologics Expenditure, 2012 - 2020;
15. Middle East Biologics Market;
15.1.1. Middle East Biologics Market Overview; 15.1.2. Middle East Biologics Historic Market, 2012 - 2016; 15.1.3. Middle East Biologics Forecast Market, 2016 - 2020; 15.1.4. Middle East Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines;
16.1.1. Africa Biologics Market Overview; 16.1.2. Africa Biologics Historic Market, 2012 - 2016; 16.1.3. Africa Biologics Forecast Market, 2016 - 2020; 16.1.4. Africa Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines;
17. Biologics Market Competitive Landscape;
17.1. Company Profiles; 17.2. Johnson & Johnson; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Pfizer Inc.; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Novartis Ag; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Abbvie; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Biologics Market;
19. Market Background: Pharmaceuticals Market;
19.1.1. Pharmaceutical Market Characteristics; 19.1.2. Pharmaceutical Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Trends And Strategies; 19.2. Pharmaceutical Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Market, 2016, By Region; 19.2.2. Global Pharmaceutical Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Market, 2016, By Country; 19.2.4. Pharmaceutical Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceuticals Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Expenditure, Global; 19.4. Pharmaceutical Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
2. Biologics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Biologics Market Customer Information;
5. Biologics Market Segmentation;
5.1. Global Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 5.2. Global Biologics Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Biologics Market Trends And Strategies; 5.4 Global Biologics Market Compared With Similar Markets, 2016; 5.5 Global Biologics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6 Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Therapeutic Proteins; 5.8.1. Market Characteristics; 5.8.2. Global Internet Broadcasting & Publishing Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9 Monoclonal Antibodies (MABS); 5.9.1. Market Characteristics; 5.9.2. Global Internet Broadcasting & Publishing Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10 Vaccines; 5.9.1. Market Characteristics; 5.10.2. Global Internet Broadcasting & Publishing Market, 2016, By Segment; 5.10.3. Market Trends And Strategies;
6. Biologics Market Regional And Country Analysis;
6.1. Global Biologics Market, 2016, By Region; 6.2. Global Biologics Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Biologics Market, 2016, By Country; 6.4. Biologics Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceuticals Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceuticals Market Segments, 2016, By Country;
7. Global Biologics Market Comparison With Macro Economic Factors;
7.1. Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Biologics Expenditure, Global;
8. Biologics Market Comparison With Macro Economic Factors Across Countries;
8.1. Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Biologics Expenditure, By Country;
9. Biologics Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.10. Global Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.11. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.12. Global Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.13. Global Number Of Pharmacies, 2016, By Country; 9.14. Global Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.15. Global New Drug Approvals, 2016, By Country; 9.16. Global Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.17. Prevalent Cases Of Thalassemia, 2014, By Country; 9.18. Global Number Of General Practitioners 2016, By Country; 9.19. Global Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Biologics Market;
10.1.1. Asia-Pacific Biologics Market Overview; 10.1.2. Asia-Pacific Biologics Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Biologics Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.2. Asia-Pacific Biologics Market: Country Analysis; 10.3. China Biologics Market; 10.3.1. China Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Biologics Historic Market, 2012 - 2016; 10.3.3. China Biologics Forecast Market, 2016 - 2020; 10.3.4. China Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.3.5. China Biologics Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Biologics Expenditure, 2012 - 2020; 10.4. India Biologics Market; 10.4.1. India Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Biologics Historic Market, 2012 - 2016; 10.4.3. India Biologics Forecast Market, 2016 - 2020; 10.4.4. India Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.4.5. India Biologics Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Biologics Expenditure, 2012 - 2020; 10.5. Japan Biologics Market; 10.5.1. Japan Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Biologics Historic Market, 2012 - 2016; 10.5.3. Japan Biologics Forecast Market, 2016 - 2020; 10.5.4. Japan Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.5.5. Japan Biologics Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Biologics Expenditure, 2012 - 2020; 10.5.7. Japan Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.5.7.2. Japan Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 10.6. Australia Biologics Market; 10.6.1. Australia Biologics Historic Market, 2012 - 2016; 10.6.2. Australia Biologics Forecast Market, 2016 - 2020; 10.6.3. Australia Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 10.6.4. Australia Biologics Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Biologics Expenditure, 2012 - 2020;
11. Western Europe Biologics Market;
11.1.1. Western Europe Biologics Market Overview; 11.1.2. Western Europe Biologics Historic Market, 2012 - 2016; 11.1.3. Western Europe Biologics Forecast Market, 2016 - 2020; 11.1.4. Western Europe Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.2. Western Europe Biologics Market: Country Analysis; 11.3. UK Biologics Market; 11.3.1. UK Biologics Market Overview; Average Salaries Of Pharmacists; 11.3.2. UK Biologics Historic Market, 2012 - 2016; 11.3.3. UK Biologics Forecast Market, 2016 - 2020; 11.3.4. UK Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.3.5. UK Biologics Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Biologics Expenditure, 2012 - 2020; 11.3.7. UK Biologics Market Comparison With Industry Metrics; 11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.3.7.2 UK Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4. Germany Biologics Market; 11.4.1. Germany Biologics Historic Market, 2012 - 2016; 11.4.2. Germany Biologics Forecast Market, 2016 - 2020; 11.4.3. Germany Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.4.4 Germany Biologics Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Biologics Expenditure, 2012 - 2020; 11.4.6 Germany Biologics Market Comparison With Industry Metrics; 11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.4.7.2 Germany Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5 France Biologics Market; 11.5.1 France Biologics Historic Market, 2012 - 2016; 11.5.2 France Biologics Forecast Market, 2016 - 2020; 11.5.3 France Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.5.4 France Biologics Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Biologics Expenditure, 2012 - 2020; 11.5.6 France Biologics Market Comparison With Industry Metrics; 11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.5.6.2 France Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6. Italy Biologics Market; 11.6.1. Italy Biologics Historic Market, 2012 - 2016; 11.6.2. Italy Biologics Forecast Market, 2016 - 2020; 11.6.3. Italy Biologics Market, 2016, By Segment; Therapeutic Proteins; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.6.4. Italy Biologics Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Biologics Expenditure, 2012 - 2020; 11.6.6. Italy Biologics Market Comparison With Industry Metrics; 11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.6.6.2 Italy Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7. Spain Biologics Market; 11.7.1. Spain Biologics Historic Market, 2012 - 2016; 11.7.2. Spain Biologics Forecast Market, 2016 - 2020; 11.7.3. Spain Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 11.7.4. Spain Biologics Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Biologics Expenditure, 2012 - 2020; 11.7.6. Spain Biologics Market Comparison With Industry Metrics; 11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 11.7.6.2 Spain Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
12. Eastern Europe Biologics Market;
12.1.1. Eastern Europe Biologics Market Overview; 12.1.2. Eastern Europe Biologics Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Biologics Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 12.2. Eastern Europe Biologics Market: Country Analysis; 12.3. Russia Biologics Market; 12.3.1. Russia Biologics Historic Market, 2012 - 2016; 12.3.2. Russia Biologics Forecast Market, 2016 - 2020; 12.3.3. Russia Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 12.3.4. Russia Biologics Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Biologics Expenditure, 2012 - 2020;
13. North America Biologics Market;
13.1.1. North America Biologics Market Overview; 13.1.2. North America Biologics Historic Market, 2012 - 2016; 13.1.3. North America Biologics Forecast Market, 2016 - 2020; 13.1.4. North America Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 13.2. North America Biologics Market: Country Analysis; 13.3. USA Biologics Market; 13.3.1. USA Biologics Historic Market, 2012 - 2016; 13.3.2. USA Biologics Forecast Market, 2016 - 2020; 13.3.3 USA Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 13.3.4. USA Biologics Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Biologics Expenditure, 2012 - 2020; 13.3.6. USA Biologics Market Comparison With Industry Metrics; 13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016; 13.3.6.2 USA Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012 - 2016;
14. South America Biologics Market;
14.1.1. South America Biologics Market Overview; 14.1.2. South America Biologics Historic Market, 2012 - 2016; 14.1.3. South America Biologics Forecast Market, 2016 - 2020; 14.1.4. South America Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 14.2. South America Biologics Market: Country Analysis; 14.3. Brazil Biologics Market; 14.3.1. Brazil Biologics Historic Market, 2012 - 2016; 14.3.2. Brazil Biologics Forecast Market, 2016 - 2020; 14.3.3. Brazil Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines; 14.3.4. Brazil Biologics Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Biologics Expenditure, 2012 - 2020;
15. Middle East Biologics Market;
15.1.1. Middle East Biologics Market Overview; 15.1.2. Middle East Biologics Historic Market, 2012 - 2016; 15.1.3. Middle East Biologics Forecast Market, 2016 - 2020; 15.1.4. Middle East Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines;
16.1.1. Africa Biologics Market Overview; 16.1.2. Africa Biologics Historic Market, 2012 - 2016; 16.1.3. Africa Biologics Forecast Market, 2016 - 2020; 16.1.4. Africa Biologics Market, 2016, By Segment; Therapeutic Proteins; Monoclonal Antibodies (MABS); Vaccines;
17. Biologics Market Competitive Landscape;
17.1. Company Profiles; 17.2. Johnson & Johnson; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Pfizer Inc.; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Novartis Ag; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Abbvie; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Biologics Market;
19. Market Background: Pharmaceuticals Market;
19.1.1. Pharmaceutical Market Characteristics; 19.1.2. Pharmaceutical Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Trends And Strategies; 19.2. Pharmaceutical Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Market, 2016, By Region; 19.2.2. Global Pharmaceutical Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Market, 2016, By Country; 19.2.4. Pharmaceutical Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceuticals Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceuticals Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Expenditure, Global; 19.4. Pharmaceutical Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Market;
20. Pharmaceuticals Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
